curcumolide

sesquiterpenoid from Curcuma wenyujin

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Leukostasis 01/01/2017 - "Curcumolide reduces diabetic retinal vascular leukostasis and leakage partly via inhibition of the p38MAPK/NF-κ B signaling." 01/01/2017 - "Curcumolide alleviated retinal vascular permeability and leukostasis and attenuated the overexpression of TNF-α and ICAM-1 in diabetic retinas. "
2.	Retinal Neovascularization 11/01/2019 - "Curcumolide has anti-angiogenic activity in HUVECs and in a murine OIR model of ischemia-induced retinal neovascularization, and it might be a potential drug candidate for the treatment of proliferative diabetic retinopathy." 11/01/2019 - "Curcumolide, a unique sesquiterpenoid from Curcuma wenyujin displays anti-angiogenic activity and attenuates ischemia-induced retinal neovascularization."
3.	Ischemia 11/01/2019 - "Curcumolide has anti-angiogenic activity in HUVECs and in a murine OIR model of ischemia-induced retinal neovascularization, and it might be a potential drug candidate for the treatment of proliferative diabetic retinopathy." 11/01/2019 - "Curcumolide, a unique sesquiterpenoid from Curcuma wenyujin displays anti-angiogenic activity and attenuates ischemia-induced retinal neovascularization."
4.	Diabetic Retinopathy (Retinopathy, Diabetic) 11/01/2019 - "Curcumolide has anti-angiogenic activity in HUVECs and in a murine OIR model of ischemia-induced retinal neovascularization, and it might be a potential drug candidate for the treatment of proliferative diabetic retinopathy."

1.	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
2.	Sesquiterpenes
3.	Retinaldehyde (Retinal)